Stay updated on Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added revision: v3.5.2; removed revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-20T04:54:33.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Release note added for site version v3.5.0 in the record history. The previous version v3.4.3 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-22T09:23:40.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a new revision entry for v3.4.3 and removed the v3.4.2 entry in the study record's history.
    Difference
    0.1%
    Check dated 2026-03-08T02:32:49.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Added revision entry v3.4.2 and removed v3.4.1 in the record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T13:47:41.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The Record History shows a new Revision: v3.4.1 added and Revision: v3.4.0 removed.
    Difference
    0.1%
    Check dated 2026-02-07T08:22:37.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The updates are UI and metadata changes: a Show glossary option, color-coded highlights, and a new revision label (v3.4.0) replacing v3.3.4. They do not modify core study data or page content.
    Difference
    1%
    Check dated 2026-01-24T01:40:17.000Z thumbnail image

Stay in the know with updates to Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.